UNI MEDICAL Sets 26 Aug 2026 Board Meeting to Approve Interim Results for 1H26

Bulletin Express08-06

Genertec Universal Medical Group Company Limited (abbreviated as UNI MEDICAL) announced that its board of directors will convene on Wednesday, 26 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026 and to authorize their publication.

The notice, dated 6 August 2026 and signed by Chairman Chen Shisu in Beijing, confirms that consideration of the 1H26 results is the key agenda item for the upcoming meeting. The board currently comprises three executive directors, four non-executive directors and four independent non-executive directors, underscoring a multi-layered governance structure ahead of the results discussion.

No further financial or operational details were disclosed in the announcement. UNI MEDICAL is incorporated in Hong Kong and its shares are listed on the Main Board of The Stock Exchange of Hong Kong. All information above is extracted directly from the company’s official filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment